In order to tap the $452-million Fexofenadine drug market, Dr Reddy’s Laboratories announced the launch of generic version of Allegra—Fexofenadine HCl—tablets in the US market
In a bid to tap the $452-million Fexofenadine drug market, Dr Reddy's Laboratories announced the launch of generic version of Allegra-Fexofenadine HCl-tablets in the US market.
The Food & Drug Administration (FDA) approved Dr Reddy's abbreviated new drug application (ANDA) for Fexofenadine HCl tablets on 12th April. The pharmaceutical firm will market the over-the-counter product under store brand labels in the US market.
The products are bio equivalent versions of Sanofi-Aventis' Allegra tablets which received Rx-to-OTC switch approval from the FDA on 24 January.
In January, the US District Court of New Jersey cleared the decks for Dr Reddy's Laboratories, the country's second-biggest drug maker, to launch the generic version of Allegra-D 24 in the US.
The US Court had also ordered Sanofi-Aventis and Albany Molecular Research, which had earlier obtained an injunction against launching of the drug, to post a security of $40 million with the court towards the possibility that the injunction had been wrongfully granted.
Earlier, based on a request filed by AMRI and Sanofi-Aventis, the US District Court had granted a preliminary injunction on the launch of Allegra-D 24 (fexofenadine hydrochloride/pseudoephedrine hydrochloride 180/240 mg extended release tablet) in June last year.
In September 2009, AMRI filed a patent infringement lawsuit in the court against Dr Reddy's for infringement of one of AMRI's patents, related to the manufacturing process for the active ingredient in Allegra, Allegra-D 12, and Allegra-D 24 Hour.
AMRI joined hands with French drug maker Sanofi-Aventis SA, which sells Allegra and filed the law suit.
Tyre manufacturer MRF reported a marginal dip in their net profits at Rs89.85 crore for the quarter ending 31 March 2011
Tyre manufacturer MRF today reported a marginal dip in their net profits at Rs89.85 crore for the quarter ending 31 March 2011.
The Chennai-based company reported net profit at Rs95.82 crore during the same period previous year, MRF said in a statement. For six months ended 31 March 2011 the net profit of the company also dipped to Rs192.03 crore from Rs215.23 crore, it said.
The net sales of the company for the quarter ending 31 March 2011 stood at Rs2,381.56 crore as against Rs1,767.58 crore it said. For six months ended March 31, 2011 the net sales of the company grew to Rs 4,547.36 crore from Rs 3,421.42 crore it said.
The survey, based on qualitative responses to 20 major parameters, gives an insight into the perception of non-financial public and private limited companies engaged in manufacturing activities about their performance and future prospects
New Delhi: The Reserve Bank of India (RBI) launched its Industrial Outlook Survey for the April-June 2011 period today, reports PTI.
The survey gives an insight into the perception of non-financial public and private limited companies engaged in manufacturing activities about their performance and future prospects, a press release issued here stated.
The assessment of business sentiments for the present quarter and expectations for the ensuing quarter are based on qualitative responses to 20 major parameters.
These include overall business and financial situations, demand indicators, price and employment expectations, profit margins, etc.
The survey provides useful forward looking inputs for policymakers, analysts and businesses, it said.
The RBI has been conducting the Industrial Outlook Survey on a quarterly basis since 1998.
The RBI has mandated the Centre for Research Planning and Action (CERPA) to conduct the survey for the current quarter on its behalf.
The CERPA would get in touch with several manufacturing companies during this quarter for seeking their valuable feedback so that it can be included in the survey, it added.
However, those manufacturing companies which are not approached by CERPA can also participate in the survey by downloading the survey schedule from RBI's official website.
CERPA, which was established in 1972, conducts social science research, provides consultancy on developmental issues, helps planners and policy makers and provides charitable services to the disadvantaged and poor sections of the country, it said.